These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7094374)

  • 1. [Effect of synthetic eel calcitonin on hypercalcemia, mainly on fractional excretion of calcium of the kidney (author's transl)].
    Sakai T
    Horumon To Rinsho; 1982 Mar; 30(3):313-6. PubMed ID: 7094374
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic effect of synthetic eel calcitonin on patients with hypercalcemia (author's transl)].
    Tomita A; Nakagawa H; Takita S; Uchikawa K; Wanibe H
    Horumon To Rinsho; 1979 Aug; 27(8):897-902. PubMed ID: 487625
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of synthetic eel calcitonin on hypercalcemia--with special reference to its acute effect].
    Sakai T; Suzuki J; Marushige F
    Horumon To Rinsho; 1979 Jan; 27(1):71-6. PubMed ID: 284873
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of hypercalcemia with Asu 1,7 eel calcitonin].
    Kudo S; Nakamura I; Sakagami M; Fukuchi S
    Horumon To Rinsho; 1979 Feb; 27(2):179-83. PubMed ID: 428129
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical application of calcium regulating hormone (author's transl)].
    Orimo H
    Horumon To Rinsho; 1980; 28(3):269-74. PubMed ID: 7398100
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synthetic salmon calcitonin as an antihypercalcemic agent for hypercalcemia in malignancy].
    Adachi I; Kimura S; Yamaguchi K; Suzuki M; Abe K
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2637-44. PubMed ID: 3740862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic infantile hypercalcemia: rapid response to treatment with calcitonin.
    Alon U; Berkowitz D; Berant M
    Child Nephrol Urol; 1992; 12(1):47-50. PubMed ID: 1606583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human synthetic calcitonin therapy for hypercalcemia of immobilization.
    Kaul S; Sockalosky JJ
    J Pediatr; 1995 May; 126(5 Pt 1):825-7. PubMed ID: 7752017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmon calcitonin in the acute treatment of moderate and severe hypercalcemia in man.
    Nilsson O; Almqvist S; Karlberg BE
    Acta Med Scand; 1978; 204(4):249-52. PubMed ID: 358762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcitonin. Biochemical and clinical aspects (author's transl)].
    Kuska J
    Przegl Lek; 1976; 33(7):672-6. PubMed ID: 981716
    [No Abstract]   [Full Text] [Related]  

  • 12. Stability and the biological activity of eel calcitonin in rats.
    Otani M; Kitazawa S; Yamauchi H; Meguro T; Orimo H
    Horm Metab Res; 1978 May; 10(3):252-6. PubMed ID: 669568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical use of calcitonin].
    Sorensen OH; Friis T; Hindberg I; Lund B
    Ugeskr Laeger; 1974 Feb; 136(8):418-23. PubMed ID: 4819007
    [No Abstract]   [Full Text] [Related]  

  • 14. Rehydration as a diagnostic and therapeutic measure in hypercalcemia including an assessment of the calcium-lowering effect of porcine calcitonin.
    Andersen M
    Acta Med Scand; 1972 Oct; 192(4):347-51. PubMed ID: 5081074
    [No Abstract]   [Full Text] [Related]  

  • 15. [Parathyroid hormone, calcitonin and bone diseases].
    Ziegler R
    Dtsch Med J; 1971 Mar; 22(6):160-3. PubMed ID: 4929556
    [No Abstract]   [Full Text] [Related]  

  • 16. Potentiation of calcitonin by corticosteroids during the treatment of the hypercalcaemia of malignancy.
    Hosking DJ; Stone MD; Foote JW
    Eur J Clin Pharmacol; 1990; 38(1):37-41. PubMed ID: 2328745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcitonin and the medullary thyroid carcinoma (author's transl)].
    Dambacher MA; Guncaga J; Heitz P; Haas HG
    Ther Umsch; 1973 Oct; 30(10):740-6. PubMed ID: 4745947
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Hypercalcemia in malignant bone diseases and its management. Studies on calcium metabolism and the use of calcitonin.
    Takatsuki K; Yodoi J; Wakisaka G; Yamamoto I; Hamamoto K
    Calcif Tissue Res; 1974; 15(2):157. PubMed ID: 4844394
    [No Abstract]   [Full Text] [Related]  

  • 20. [Calcitonin therapy of the hypercalcemia syndrome].
    Várvölgyi C; Mátyus J; Lörincz I
    Orv Hetil; 1988 Jun; 129(25):1343-4. PubMed ID: 3194130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.